Bronfman E.L. Rothschild L.P. grew its position in Procter & Gamble Company (The) (NYSE:PG) by 15.7% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 39,071 shares of the company’s stock after acquiring an additional 5,298 shares during the quarter. Bronfman E.L. Rothschild L.P.’s holdings in Procter & Gamble were worth $3,405,000 as of its most recent SEC filing.
Other hedge funds have also recently made changes to their positions in the company. Asset Planning Services Ltd. lifted its position in shares of Procter & Gamble by 0.4% in the 2nd quarter. Asset Planning Services Ltd. now owns 1,191 shares of the company’s stock worth $104,000 after acquiring an additional 5 shares during the period. Blume Capital Management Inc. lifted its position in shares of Procter & Gamble by 25.4% during the 2nd quarter. Blume Capital Management Inc. now owns 1,482 shares of the company’s stock worth $129,000 after buying an additional 300 shares during the period. Riggs Asset Managment Co. Inc. lifted its position in shares of Procter & Gamble by 11.9% during the 1st quarter. Riggs Asset Managment Co. Inc. now owns 1,603 shares of the company’s stock worth $144,000 after buying an additional 170 shares during the period. Winfield Associates Inc. lifted its position in shares of Procter & Gamble by 0.7% during the 2nd quarter. Winfield Associates Inc. now owns 2,260 shares of the company’s stock worth $197,000 after buying an additional 15 shares during the period. Finally, Watermark Asset Management Inc. bought a new position in shares of Procter & Gamble during the 1st quarter worth approximately $201,000. Institutional investors own 59.54% of the company’s stock.
Procter & Gamble Company (NYSE:PG) traded down $0.01 during mid-day trading on Wednesday, reaching $91.40. The company had a trading volume of 8,683,000 shares, compared to its average volume of 7,383,511. Procter & Gamble Company has a 12-month low of $82.61 and a 12-month high of $94.67. The firm has a market cap of $231,903.34, a PE ratio of 22.97, a price-to-earnings-growth ratio of 2.94 and a beta of 0.67. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.91 and a quick ratio of 0.75.
The firm also recently declared a quarterly dividend, which was paid on Wednesday, November 15th. Investors of record on Friday, October 20th were issued a dividend of $0.6896 per share. The ex-dividend date of this dividend was Thursday, October 19th. This represents a $2.76 dividend on an annualized basis and a yield of 3.02%. Procter & Gamble’s dividend payout ratio is 48.51%.
In other news, insider R. Alexandra Keith sold 1,298 shares of Procter & Gamble stock in a transaction on Wednesday, November 29th. The stock was sold at an average price of $89.11, for a total value of $115,664.78. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Marylynn Fergusonmchugh sold 4,363 shares of Procter & Gamble stock in a transaction on Tuesday, November 7th. The shares were sold at an average price of $87.00, for a total value of $379,581.00. Following the completion of the sale, the insider now directly owns 85,495 shares of the company’s stock, valued at $7,438,065. The disclosure for this sale can be found here. Insiders have sold a total of 21,575 shares of company stock valued at $1,927,095 over the last ninety days. Insiders own 0.35% of the company’s stock.
Several equities analysts recently commented on the company. Jefferies Group restated a “buy” rating and set a $92.44 target price (down previously from $103.00) on shares of Procter & Gamble in a research report on Thursday, August 17th. Vetr upgraded Procter & Gamble from a “sell” rating to a “hold” rating and set a $93.02 target price for the company in a research report on Friday, September 15th. Royal Bank Of Canada restated an “outperform” rating and set a $80.00 target price on shares of Procter & Gamble in a research report on Wednesday, September 6th. Morgan Stanley cut their target price on Procter & Gamble from $91.00 to $90.00 and set an “equal weight” rating for the company in a research report on Tuesday, October 24th. Finally, Zacks Investment Research downgraded Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Wednesday, October 18th. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and eight have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $87.81.
TRADEMARK VIOLATION WARNING: “Bronfman E.L. Rothschild L.P. Increases Holdings in Procter & Gamble Company (The) (PG)” was first published by Community Financial News and is owned by of Community Financial News. If you are accessing this piece on another site, it was illegally copied and reposted in violation of United States and international trademark and copyright legislation. The original version of this piece can be viewed at https://www.com-unik.info/2017/12/06/bronfman-e-l-rothschild-l-p-increases-holdings-in-procter-gamble-company-the-pg.html.
Procter & Gamble Company Profile
The Procter & Gamble Company is focused on providing branded consumer packaged goods to the consumers across the world. The Company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care, and Baby, Feminine & Family Care. The Company sells its products in approximately 180 countries and territories primarily through mass merchandisers, grocery stores, membership club stores, drug stores, department stores, distributors, baby stores, specialty beauty stores, e-commerce, high-frequency stores and pharmacies.
What are top analysts saying about Procter & Gamble Company (The)? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Procter & Gamble Company (The) and related companies.